Table 2. Treatment response (intention-to-treat analysis, n=49).
| Response | Gallbladder cancer (n=10) | Intrahepatic CCC (n=30) | Extrahepatic CCC (n=9) | All patients (n=49) |
|---|---|---|---|---|
| CR | — | — | — | — |
| PR | 4 (40.0%) | 7 (23.3%) | 1 (11.1%) | 12 (24.5%) |
| SD | 4 (40.0%) | 9 (30.0%) | 4 (44.4%) | 17 (34.7%) |
| PD | — | 12 (40.0%) | 4 (44.4%) | 16 (32.7%) |
| NEa | 2 (20.0%) | 2 (6.7%) | — | 4 (8.2%) |
Abbreviations: CR=complete response; PR=partial response; SD=stable disease; PD=progressive disease; NE=not evaluable; CCC=cholangiocellular carcinoma.
Four patients were lost to follow-up.